Apr 26
|
Decoding DexCom Inc (DXCM): A Strategic SWOT Insight
|
Apr 25
|
Dexcom's profit beats estimates on strong glucose monitor demand
|
Apr 25
|
DexCom (DXCM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
|
Apr 25
|
DexCom Inc (DXCM) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
|
Apr 25
|
Dexcom Plummets After Raising Its Sales Guidance For The Year — But Not Enough
|
Apr 25
|
Dexcom Reports First Quarter 2024 Financial Results
|
Apr 24
|
Wall Street Bulls Look Optimistic About DexCom (DXCM): Should You Buy?
|
Apr 23
|
DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
|
Apr 23
|
Boston Scientific, Dexcom and Edwards next as earnings season rolls on
|
Apr 22
|
Ahead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
|
Apr 22
|
Zacks Investment Ideas feature highlights: Vertiv, Align Technology and DexCom
|
Apr 19
|
Even IBD 50 Medical Products Stocks Don't All Look Healthy In This Sick Market
|
Apr 19
|
Dexcom In Buy Zone After Launch Of Prescription-Free Diabetes Monitor; Earnings Due Next Week
|
Apr 19
|
3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback
|
Apr 16
|
EVP Strategy and Corporate Dev Matthew Dolan Sells Shares of DexCom Inc (DXCM)
|
Apr 16
|
Zacks Industry Outlook Highlights Edwards Lifesciences, DexCom and STERIS
|
Apr 16
|
14 Best 52-Week High Stocks To Invest In Now
|
Apr 15
|
DexCom (DXCM) Stock Moves -1.16%: What You Should Know
|
Apr 15
|
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
|
Apr 15
|
DexCom (DXCM), MD Revolution Unite to Boost Diabetes Management
|